USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Corcym S.R.L.

USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Corcym ranks #24,142 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.

#24,142
of 49,997 US assignees by volume
Top 21%
by Innovation Score (46.2/100)
19.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24142 · Foreign Corporation #24,142 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,142/49,997
  • PHOTO-FINISH Convey
  • CPC-NARROW A61F · 3 areas
  • INNOV-PAR 46.2/100
  • CLAIMS-RICH 19.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Convey, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Corcym’s 46.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Corcym

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Corcym's Innovation Score is 46.2/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Corcym?

Each dot is one of Corcym’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Corcym’s own 19.2 claims/patent is ABOVE the 11.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Corcym vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 5101520 Granted patents (volume) Avg claims / patent Convey, LLC - 11, 16.91ConveyCooper Crouse-hinds GMBH - 11, 10.18Cooper Crouse-hin…Coors Brewing Company - 11, 7.64Coors BrewingCoprecitec, S.L. - 11, 11.64Coprecitec S LCoreteq Systems Ltd - 11, 14.09Coreteq SystemsCorob S.P.A. - 11, 12.27Corob S P ACosmex Co., Ltd. - 11, 11.64CosmexCozzini LLC - 11, 12CozziniCorcym S.R.L. - 11, 19.18Corcym S R L
Corcym vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Corcym's grants concentrate

Corcym S.R.L. is a focused PatentsView assignee: 3 CPC subclasses with 90.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2022. By volume, Corcym sits between Convey, LLC and Cozzini LLC.

Corcym's three-year grant acceleration

Corcym S.R.L. shows 8 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Corcym's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Corcym holds 11 patents at rank #24,084, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Corcym

By rank, the assignees closest to #24,084 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Corcym's primary technology class.

Corcym's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20212022202320242025 1
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Corcym S.R.L. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 2 18.2%
2022 1 9.1%
2023 1 9.1%
2024 6 54.5%
2025partial year 1 9.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Corcym S.R.L.'s patent record in context - here's where to go next.

  • Corcym S.R.L.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 90.9% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #24,142 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Corcym S.R.L. against Convey, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 46.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.